Protective effect of selenium supplementation on antioxidant defence and cardiovascular diseases in alloxan diabetic rats
Paper Details
Protective effect of selenium supplementation on antioxidant defence and cardiovascular diseases in alloxan diabetic rats
Abstract
To investigate the protective effect of selenium supplementation in the cardiovascular diseases associated with diabetes mellitus caused by lipid peroxidation and oxidative stress. Thirty five male albino (wistar) rats of 06 weeks of age were randomly divided into five groups of seven each. Two groups were pre-treated for 10 days by sodium selenite (2 mg/kg.bw/d) via orogastric route. The first group was served as the control, the second as the normal treated intra peritoneally by selenium (1.89 mg/kg.bw/d). Three groups were intra peritoneally injected with alloxan (150 mg/kg.bw) to induce diabetes. One diabetic group treated intra peritoneally by insulin (3UI/100g. bw), another diabetic group (pre-treated by selenium 2 mg/kg.bw/d for 10 days) treated intra peritoneally by selenium (1.89 mg/kg.bw/d) for further three weeks. The administration of alloxan significantly increased blood glucose, total cholesterol, LDL-C, triglycerides, lipids, heart MDA content, GST activity. In contrast blood HDL-C, insulin levels, G6PDH activity, heart GSH, GPx, Catalase activities were significantly decreased. Supplementation of sodium selenite restores the parameters measured compared to untreated diabetic rats and diabetic treated by insulin. To conclude the present study shows that treatment of diabetic rats with sodium selenite prevented cardiovascular diseases induced by hyperlipemia, lipid peroxidation and free radicals generated during diabetes.
Aebi. 1984. Catalase . In L. Packer (Ed), methods in enzymology, Academic press, Orlando, 105: 121-126.
Altan VM. 2003. The pharmacology of diabetic complications. Current Medicinal Chemistry 10, 1317– 1327. DOI: 10.2174/0929867033457287
Assmann G, Schulte H. 1988. The Prospective Cardiovascular Munster (PROCAM) study: prevalence of hyperlipidemia in persons with hypertension and/or diabetes mellitus and the relationship to coronary heart disease, American Heart Journal. 116, 1713–1724. DOI: 10.1016/0002-8703(88)90220-7
Ayaz M, Ozdemir S, Ugur M, Vassort G and Turan B. 2004. Effects of selenium on altered mechanical and electrical cardiac activities of diabetic rat, Arch. Biochemistry and Biophysics. 426, 83–90. doi: 10.1016/j.abb.2004.04.008
Ayaz M, Can B, Ozdemir S and Turan B. 2002. Protective effect of selenium treatment on diabetes-induced myocardial structural alterations, Biological Trace Element Research. 89, 215–226. DOI: 10.1385/BTER:89:3:215
Battell M L, Delgatty H L M and McNeill J H. 1998. Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats, Molecular. Cellular Biochemistry. 179, 27–34. DOI: 10.1023/A:1006819227506
Becker DJ, Reul B, Ozcelikay A, Buchent J P, Henquin JC and Brichard SM. 1996. Oral selenate improves glucose homeostasis and partly reverses abnormal expression of liver glycolytic and gluconeogenic enzyme in diabetic rats. Diabetologia; 39, 3-11. DOI: 10.1007/BF00400407
Berg EA, Wu JY, Compbell L, Kagey M And Stapleton SR. 1995. Insulin like effect of vanadate and selenate on the expression of G6PD and fatty acid synthase in diabetic rats. Biochemistry, 77, 919-924.
Bidlack WR. 1996. Interrelationships of food, nutrition health: the National Association of State Universities and Land Grant Colleges White Paper. American Journal of Nutrition. 15, 422–33.
Bradford M. 1976. A rapid and sensitive method for the quantities of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochemistry, 72:248–54. doi:10.1016/0003-2697(76)90527-3
Buccolo G, Harold D. 1973. Quantitative determination of serum triglycerides by use of enzymes. Clinical Chemistry. 19(5), 476-482.
Buege JA, Aust SD. 1984. Microsomal lipid peroxidation. Methods Enzymol, 105:302-310.
Charpentier G. 2002. Oral combination therapy for type 2 diabetes. Diabetes and Metabolism Research and Reviews. 18 (Suppl3), S70– S76.
Ding H, Pen R., Chen J. 1997. Effect of selenite and allitridi on the diabetic mice. Acta Nutr. Sini. 19: 384–387.
Doi K, Sawada F, Toda G. 2001. Alteration of antioxidants during the progression of heart disease in streptozotocin-induced diabetic rats, Free Radical Research. 34(3), 251–261. doi:10.1080/10715760100300231
Ezaki O. 1990. The insulin-like effects of selenate in rat adipocytes, Journal of Biololy and Chemistry. 265, 1124–1130.
Flohe , Gunzler . 1984. Analysis of glutathione peroxidase, Methods Enzymol. 105, 114–121.
Friedewald WT, Levei RI, Fridrickson DS.1972. Estimation of the concentration of low density lipoproteins cholesterol in plasma without use of the ultra centrifugation. Clinical and Chemical research. 18, 499-502.
Giugliano D, Ceriello A, Paolisso G.1996. Oxidative stress and diabetic vascular complications. Diabetes Care. 19, 257–267. doi: 10.2337/diacare.19.3.257
Guerrero-Romero F and Rodriguez-Moran M. 2005. Complementary therapies for diabetes: the case of chromium. Magnesium Antioxidants. 36, 250–7.
Habig WH, Pabst MJ, Jakoby WB. 1974. Glutathione-S-transferase the first step in mercapturic acid formation. Journal of Biology and Chemistry. 249, 7130–9.
Heart H & Sung C.K. 2003. Insulin-like and non-insulin-like selenium actions in 3T3-L1 adipocytes, Journal of Cellular and Biochemistry. 88, 719–731. Doi: 10.1002/jcb.10395
Hei YJ, Farahbakhshian S, Chen X. 1998. Stimulation of MAP kinase and S6 kinase by vanadium and selenium in rat adipocytes. Molecular and Cellular Biochemistry, 178, 367–375. DOI 10.1023/A:1006819906820
Kaplan A. 1984. Lipids. Journal of Clinical Chemistry, 918-919.
Kaplan A . 1984. Glucose. The C.V Mosby CO. St Louis Toronto. Princelon, Journal of Clinical Chemistry. 1032 -1036.
Koehler H, Peters HJ, Pankau H, Duck H.J. 1988. Selenium in cardiology and angiology. Biological Trace Elements Research. 15, 157–167.
Koller L D and Exon J H. 1986. The two faces of selenium-deficiency and toxicity are similar in animals and man. Vet. Research Journal. 50, 297– 306.
Lohr,GW, Waller HD. 1974. Glucose-6-Phosphate Dehydrogenase. Method of Enzymatic Analysis,3rd Edition- Varlag Chemie, Wehnheim; p.636.
Mak DH, Ip SP, Li PC, Poon MK and Ko K. M. 1996. Alterations in tissue glutathione system in streptozotocin-induced diabetic rats. Molecular and Cellular Biochemistry. 162(2), 153–158. DOI: 10.1007/BF00227543
Maritim AC, Sanders Ra and Watkins JBIII. 2003. Diabetes oxidative stress, and anti oxidant. A review. Biochemistry and Toxicology Journal. 17, 24-38.
McNeill JH, Delgatty HLM and Battell ML. 1991. Insulinlike effects of sodium selenate in streptozotocin-induced diabetic rats, Diabetes 40, 1675–1678. doi: 10.2337/diab.40.12.1675
Naito HK, Kaplan A. 1984. Cholesterol. Clinical and Chemical the C.V Mosby CO. St Louis Toronto. Princeton. 1194-11206 and 437.
Naito HK, Kaplan A. 1984. HDL–Cholesterol. Clinical and Chemical the C.V Mosby CO. St Louis Toronto. Princeton :1207-1213 and 437.
Ness GC, Zhao Z. and Wiggins L. 1994. Insulin and glucagon modulate hepatic 3-hydroxy-methyl glutaryl-coenzyme A. Journal of Biological Chemistry. 269, 29168-29172.
Neve J. 1991. Physiological and nutritional importance of selenium, Experienta 47, 187–193.
Odetti P, Travers ON, Cosso,L, Noberasco G, Pronzato MA and Marinariu M. 1996. Good glycemic control reduces oxidation and glycation end-products in collagen of diabetic rats. Diabetologia. 39, 1440-1447. DOI: 10.1007/s001250050596
Opie LH. 1970. Effect of fatty acid on contractility and rhythm of the heart. Nature (London) 227, 1055– 1066.
Rodrigues BB, Goyal RK, McNeill JH. 1986. Effects of hydralazine on streptozotocin induced diabetic rats: Prevention of hyperlipidemia and improvement in cardiac function. Journal of Pharmacological. 237, 292– 299.
Rodrigues BB, McNeill JH. 1986. Cardiac function in spontaneously hypertensive diabetic rats. American Journal of Physiology. 251, H571–H580.
Rosen P, Du X, Tschope D. 1998. Role of oxygen-derived radicals for vascular dysfunction in the diabetic heart: prevention by alpha-tocopherol, Molecular and Cellular Biochemistry. 188, 103–111.
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafemen DG and Hoekstra WG. 1973. Selenium: biochemical role as a component of glutathione peroxidase, Science 179, 588–590.
Sapin, R. Le Galudec V, Gasser F, Pinget M, Grucker D. 2001. Elecsys insulin Assay; Free Insulin Determination and the absence of Cross-Reactivity with Insulin Lispro. Clinical Chemistry. 47, 602-605.
Stapleton SR, Garlock GL, Foellmi-Adams L. 1997. Selenium potent stimulator of tyrosyl phosphorylation and activator of MAP kinase. Biochemica and Biophysica Acta, 1355, 259–269. DOI: 10.1016/S0167-4889(96)00140-1
Stapleton SR. 2000. Selenium: an insulin mimetic. Cellular and Molecular life Science. 57, 1874-1879. DOI: 10.1007/PL00000669
Strojek K. 2003. Features of macrovascular complications in type 2 diabetic patients. Acta Diabetologica, 40 (Suppl 2), S334– S337. DOI : 10.1007/s00592-003-0115-x
Suthagar E, Soudamani S, Yuvaraj S ,Ismail khan A, Aruldhas MM, Balasubramanian K. 2009. Effects of streptozotocin induced diabetes and insulin replacement on rat ventral prostate. Biomed pharmacother, 63, 43-50. Doi: 10.1016/j.biopha.2008.01.002
Veki H, Ohkura Y, Moxoyashiki T, Tominage N. and Morita T. 1993. Increase in lipoprotein lipase activity in isolated rat adipose tissue by selenate. Biology and Pharmacology Bull. 16, 6-10.
Weckbercker G, Cory JG. 1988. Ribonucleotide reductase activity and growth of Glutathione-depended mouse Leukemia L1210 cells in vitro. Cancer Letter, 40, 257-264. PMID: 3289734
Zhang, Z, Yu.J and Stanto, RC. 2000. A method for determination of pyridine nucleotides using a single extract. Analytical biochemistry, 285, 163- 167. DOI: 10.1006/abio.2000.4701
Zhong GG, Jiang Y, Li ZB, Zhang BG, Zhang WJ, Yue G. 1990. Protective action of selenium and manganese on xanthine and xanthine oxidase induced oxidative damage to cultured heart cells. Chinese Medical Journal. 103, 735–742. PMID:2123774
S.Boussekine, N.Bouzerna, R.Rouabhi (2014), Protective effect of selenium supplementation on antioxidant defence and cardiovascular diseases in alloxan diabetic rats; IJB, V4, N5, March, P1-10
https://innspub.net/protective-effect-of-selenium-supplementation-on-antioxidant-defence-and-cardiovascular-diseases-in-alloxan-diabetic-rats/
Copyright © 2014
By Authors and International
Network for Natural Sciences
(INNSPUB) https://innspub.net
This article is published under the terms of the
Creative Commons Attribution License 4.0